Published in Infect Immun on February 01, 2006
Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. Mol Immunol (2008) 1.60
Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans. J Autoimmun (2013) 1.07
Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice. Infect Immun (2009) 0.99
Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis. Immunobiology (2012) 0.87
λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies. J Infect Dis (2015) 0.78
Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate. Medicine (Baltimore) (2015) 0.75
V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons. Clin Vaccine Immunol (2011) 0.75
The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med (1977) 3.78
Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity (2000) 3.49
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis (1999) 3.15
Antibody engineering for the analysis of affinity maturation of an anti-hapten response. EMBO J (1988) 2.81
The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today (1994) 2.71
Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis (1998) 2.26
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clin Diagn Lab Immunol (1998) 1.93
Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. Infect Immun (1999) 1.83
Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F. Infect Immun (2002) 1.62
Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J Infect Dis (1999) 1.58
Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates. J Immunol (1995) 1.47
Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults. J Infect Dis (2002) 1.33
Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B. Infect Immun (1999) 1.32
Immunogenetic analysis of the immune response to pneumococcal polysaccharide. Eur J Immunol (2000) 1.28
Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B. Infect Immun (2004) 1.24
Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F. Infect Immun (1997) 1.12
Strong intrinsic biases towards mutation and conservation of bases in human IgVH genes during somatic hypermutation prevent statistical analysis of antigen selection. Immunology (1998) 1.11
Can isotype switch modulate antigen-binding affinity and influence clonal selection? Eur J Immunol (2000) 1.07
Problems in using statistical analysis of replacement and silent mutations in antibody genes for determining antigen-driven affinity selection. Immunology (2005) 1.06
Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses. Immunology (1996) 1.05
Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen. J Exp Med (1992) 1.01
The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity. J Immunol Methods (1993) 1.01
Correlation between the avidity of mouse-human chimeric IgG subclass monoclonal antibodies measured by solid-phase elution ELISA and biospecific interaction analysis (BIA). J Immunol Methods (1997) 0.99
Immunogenicity of pneumococcal conjugate vaccines. Pediatr Infect Dis J (2000) 0.97
Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation. Immunology (1998) 0.95
Base-specific sequences that bias somatic hypermutation deduced by analysis of out-of-frame human IgVH genes. J Immunol (1998) 0.92
Role of kappa II-A2 light chain CDR-3 junctional residues in human antibody binding to the Haemophilus influenzae type b polysaccharide. J Immunol (1998) 0.91
The response in old mice: positive and negative immune memory after priming in early age. Int Immunol (2001) 0.90
A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased VH3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons. J Infect Dis (2000) 0.88
Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations. EMBO J (1995) 0.86
Structural requirements of the major protective antibody to Haemophilus influenzae type b. Infect Immun (1999) 0.82
Preparation of human-mouse heterohybridomas against an immunising antigen. J Immunol Methods (2000) 0.79
Somatic hypermutation in T-independent and T-dependent immune responses to Haemophilus influenzae type b polysaccharide. Clin Immunol Immunopathol (1998) 0.79
Haemophilus influenzae type b polysaccharides-protein conjugate vaccine elicits a more diverse antibody repertoire in infants than in adults. J Immunol (1998) 0.77
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun (2001) 2.86
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis (2000) 2.57
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. J Clin Microbiol (2000) 1.97
A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin Diagn Lab Immunol (1999) 1.81
Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet (1999) 1.65
Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol (2008) 1.47
Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol (2002) 1.42
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine (1999) 1.33
Immunogenetic analysis of the immune response to pneumococcal polysaccharide. Eur J Immunol (2000) 1.28
Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines. J Infect Dis (2001) 1.26
Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin Exp Immunol (2007) 1.25
Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale. Am J Epidemiol (1965) 1.24
Exposure of histone antigenic determinants in chromatin. Biochemistry (1975) 1.18
A novel splicing factor is an integral component of 200S large nuclear ribonucleoprotein (InRNP) particles. EMBO J (1991) 1.17
Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children. J Infect Dis (2001) 1.16
Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology. Clin Exp Immunol (2007) 1.12
Organ donation and fire insurance--an analogy? Pharos Alpha Omega Alpha Honor Med Soc (1999) 1.11
Colitis in chronic granulomatous disease. Arch Dis Child (2001) 1.11
Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children. Acta Paediatr (2003) 1.10
Recurrent hemichorea following striatal lesions. Arch Neurol (1974) 1.09
Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia. Vaccine (2008) 1.08
Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression. Eur J Immunol (2000) 1.05
Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses. Immunology (1996) 1.05
CT features of hyperostosing meningioma en plaque. AJR Am J Roentgenol (1987) 1.03
Conjugate vaccines. Clin Exp Immunol (2000) 1.01
Evaluation of pulmonary function in neuromuscular disease. Arch Neurol (1981) 1.01
Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J Clin Invest (1978) 1.00
Chromatin structure visualization by immunoelectron microscopy. Cell (1976) 0.97
Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Immunol (2000) 0.95
Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media. Pediatr Infect Dis J (1999) 0.95
A direct comparison of the antigen-specific antibody profiles of intravenous immunoglobulins derived from US and UK donor plasma. Vox Sang (2002) 0.94
Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine (2001) 0.94
Hospital admissions in children due to pneumococcal pneumonia in England. J Infect (1998) 0.92
Histone distribution in chromosomes revealed by antihistone sera. Exp Cell Res (1976) 0.91
A controlled clinical trial of baclofen as protective therapy in early Huntington's disease. Ann Neurol (1989) 0.90
Dermatofibrosarcoma protuberans of the scalp: a series of cases. J Am Acad Dermatol (1989) 0.90
Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study. Clin Microbiol Infect (2013) 0.90
Some therapeutic observations in Wilson's disease. Adv Neurol (1983) 0.89
Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J (1996) 0.89
Managed care and the survival of neurology referral centers. A commitment to centers of excellence. Arch Neurol (1997) 0.88
"I an sniling!": Möbius' syndrome inside and out. J Child Neurol (1986) 0.88
Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet (2003) 0.88
Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicing. Proc Natl Acad Sci U S A (1991) 0.87
Clinical manifestations of disease in X-linked carriers of chronic granulomatous disease. J Clin Immunol (2013) 0.87
X-linked lymphoproliferative disease: three atypical cases. Clin Exp Immunol (2001) 0.86
Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life. Arch Dis Child Fetal Neonatal Ed (2004) 0.85
Assessment of Streptococcus pneumoniae pilus islet-1 prevalence in carried and transmitted isolates from mother-infant pairs on the Thailand-Burma border. Clin Microbiol Infect (2011) 0.85
Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly. Blood (2000) 0.84
The epidermal growth factor receptor as a substrate for a kinase-splitting membranal proteinase. J Biol Chem (1988) 0.84
Heterogeneity in the interaction of chromatin subunits with anti-histone sera visulatized by immuno-electron microscopy. Exp Cell Res (1978) 0.83
Characterisation of an outer membrane protein of Moraxella catarrhalis. FEMS Immunol Med Microbiol (1997) 0.83
Influence of muscle wasting on oral glucose tolerance testing. Clin Sci (Lond) (1983) 0.83
Muscle insulin resistance in myotonic dystrophy: effect of supraphysiologic insulinization. Neurology (1980) 0.82
Huntington's disease: treatment with muscimol, a GABA-mimetic drug. Ann Neurol (1978) 0.82
Computerized tomography in acute hemorrhagic leukoencephalopathy: a case report. Neurology (1979) 0.81
Pericardial effusions in two boys with chronic granulomatous disease. Pediatr Radiol (1999) 0.80
Preparation of human-mouse heterohybridomas against an immunising antigen. J Immunol Methods (2000) 0.79
Slow eye movements, with absent saccades, in a patient with hereditary ataxia. Arch Neurol (1977) 0.79
Increased expression of interleukin-13 but not interleukin-4 in CD4+ cells from patients with the hyper-IgE syndrome. Clin Exp Immunol (2002) 0.79
Immunological probes for chromatin structure. Cold Spring Harb Symp Quant Biol (1978) 0.78
Antigenicity of histones in various chromatins. Biochim Biophys Acta (1980) 0.78
Percutaneous obliteration of a postoperatively persistent vertebral arteriovenous fistula. AJNR Am J Neuroradiol (1989) 0.78
Such queer moons: Frederic Eugene Basil Foley (1891-1966). Semin Neurol (1988) 0.77
Measles vaccination and inflammatory bowel disease. Lancet (1998) 0.77
Treatment of amyotrophic lateral sclerosis. Adv Neurol (1977) 0.77
Effects of various dressings on skin and subcutaneous temperatures. A comparison. Arch Surg (1967) 0.77
Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed (2003) 0.76
Hematopoietic-cell transplantation for chronic granulomatous disease. N Engl J Med (2001) 0.76
Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease. Ann Neurol (1988) 0.76
Morphologic cerebral asymmetries and handedness. Arch Neurol (1995) 0.75
Violence: resensitizing the inured. Arch Neurol (1992) 0.75
Brodmann's numbers. Neurology (1993) 0.75
Nisus steps forth. Neurology (2001) 0.75
Autism, inflammatory bowel disease, and MMR vaccine. Lancet (1998) 0.75
Neuroradiology case of the day. AJR Am J Roentgenol (1988) 0.75
Immune response and host-pathogen interactions. Methods Mol Med (2001) 0.75
Gower's sign. Semin Neurol (1991) 0.75
A battered doll. Arch Neurol (1984) 0.75
Cool heads and hot spots: surface thermometry and neurothermography. Semin Neurol (1987) 0.75
Proceedings: Exposure of histone antigenic determinants in chromatin. Isr J Med Sci (1975) 0.75
THE MANAGEMENT OF FRACTURE OF THE FEMUR. Ann Surg (1930) 0.75
The great names of our profession. Robert Bentley Todd (1809-1860). Semin Neurol (1986) 0.75
Neuropathy after pyridoxine or toxic contaminants. Neurology (1986) 0.75
Identification of nuclear RNP proteins as pre-mRNA splicing factors. Mol Biol Rep (1990) 0.75
Double-blind evaluation of deanol in tardive dyskinesia. JAMA (1978) 0.75
Hybridization kinetics of ribonucleic acid and deoxyribonucleic acid from antigen-stimulated mouse spleen cells. J Immunol (1976) 0.75
Hib IgG persistence following early booster dose. Arch Dis Child (2005) 0.75
Molecular homogeneity of the histone content of HeLa chromatin subunits. Biochemistry (1977) 0.75
Butterflies of the soul--Charles Marc Pomerat (1905-1964). Semin Neurol (1994) 0.75
Immunodeficiency syndromes and recurrent infection. Br J Hosp Med (1997) 0.75
Isolation and partial characterization of plasma membranes bearing human fetal-associated antigens. Cancer Res (1977) 0.75
Guillain-Barré syndrome following Campylobacter jejuni enteritis. Arch Neurol (1987) 0.75
Investigation of the immune system in recurrent infection. Br J Hosp Med (1999) 0.75
Huntington's disease: treatment with muscimol, a GABA-mimetic drug. Trans Am Neurol Assoc (1977) 0.75
CONTRIBUTION TO THE STUDY OF BURNS, THEIR CLASSIFICATION AND TREATMENT. Ann Surg (1927) 0.75
Even a blind hog. Robert J. Joynt, M.D., Ph.D. Semin Neurol (1994) 0.75
Guillain-Barré syndrome following Campylobacter jejuni enteritis. Arch Neurol (1988) 0.75
Paul Ehrlich and 606. Arch Neurol (1986) 0.75
The fooling sickness--fictitious, factitious, or faked? Semin Neurol (1990) 0.75